Recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough could lead to potential non-toxic therapies for cancer patients. The researchers, who published their findings in the April issue of Cancer Cell, have identified a drug that targets an oncogene known as BCL6.
http://www.biologynews.net/archives/2010/05/11/scientists_design_new_drug_type_to_kill_lymphoma_cells.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment